BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
27 hedge funds and large institutions have $7.68M invested in Bellicum Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Holders
27
Holding in Top 10
–
Calls
$3.75M
Puts
$7K
Top Buyers
| 1 | +$396K | |
| 2 | +$217K | |
| 3 | +$26.7K | |
| 4 |
BlackRock
New York
|
+$22.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$15.6K |
Top Sellers
| 1 | -$1.02M | |
| 2 | -$1.02M | |
| 3 | -$292K | |
| 4 |
Morgan Stanley
New York
|
-$174K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$89K |